PharmaTher Holdings Ltd. (PHRM) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

29.4 k

Shareholding (May 2024)

FII

0.00%

Held by 1 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CAD 10 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.12

Return on Equity

-155.94%

Price to Book

10.18

Revenue and Profits:

Net Sales:

(Quarterly Results - Feb 2025)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-34.21%

6 Months

-45.65%

1 Year

-44.44%

2 Years

31.58%

3 Years

-26.47%

4 Years

-78.81%

5 Years

0.0%

PharmaTher Holdings Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

0.00%

EBIT Growth (5y)

26.83%

EBIT to Interest (avg)

-2.63

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.06

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.00%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

13.28

EV to EBIT

-7.75

EV to EBITDA

-7.75

EV to Capital Employed

-12.15

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-155.94%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

No Signal

Bollinger Bands

Sideways

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : May 2024

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Feb'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Feb 2025 is 0.00% vs 0.00% in Feb 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Feb 2025 is 0.00% vs 50.00% in Feb 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Feb'25",
        "Feb'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.40",
          "val2": "-0.40",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.40",
          "val2": "-0.40",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - May'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended May 2024 is 0.00% vs 0.00% in May 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended May 2024 is 51.56% vs -60.00% in May 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "May'24",
        "May'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.10",
          "val2": "-4.00",
          "chgp": "22.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.20",
          "val2": "-2.60",
          "chgp": "92.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.10",
          "val2": "-6.40",
          "chgp": "51.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Feb'25 - YoY

Feb'25

Feb'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.40

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-0.40

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Feb 2025 is 0.00% vs 0.00% in Feb 2024

Consolidated Net Profit

YoY Growth in quarter ended Feb 2025 is 0.00% vs 50.00% in Feb 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - May'24

May'24

May'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-3.10

-4.00

22.50%

Interest

0.00

Exceptional Items

-0.20

-2.60

92.31%

Consolidate Net Profit

-3.10

-6.40

51.56%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended May 2024 is 0.00% vs 0.00% in May 2023

Consolidated Net Profit

YoY Growth in year ended May 2024 is 51.56% vs -60.00% in May 2023

All Annual Results

Company CV

About PharmaTher Holdings Ltd.

PharmaTher Holdings Ltd.

Pharmaceuticals & Biotechnology

Newscope Capital Corporation is a Canada-based specialty life sciences company. Through its subsidiary, PharmaTher Inc., it is focused on repurposing psychedelic-derived drugs with artificial intelligence (AI). Its product pipeline focuses on infectious diseases and rare disorders in pain and central and peripheral nervous systems. It offers panaceAI, which is an artificial intelligence drug repurposing platform.

Company Coordinates

Company Details

1100 - 1111 Melville Street , Vancouver BC : V6E 3V6

Tel:

Registrar Details